Will US Covid vaccine patent waiver lead to more jabs in India? Not really - News Summed Up

Will US Covid vaccine patent waiver lead to more jabs in India? Not really


The global inequityMass immunisation is the only way to end the pandemic but rising global inequality in vaccine access stands as a colossal hurdle. According to WHO, nearly 80% of Covid-19 vaccines have been administered in just 10 rich countries, while more than 2.5 billion people await their first shots. Also Read | A new chapter for the TRIPS waiver proposalWTO’s director general Ngozi Okonjo-Iweala has said the body would take up the issue of IP waiver for Covid vaccine in December. In their paper, “A network analysis of Covid-19 mRNA vaccine patents”, Gaviria and Kilic explain that this vaccine platform uses multiple technologies, including the main mRNA technology, lipid nanoparticle technology and a delivery-system. It depends on voluntary sharing of recipes and data, for which no Covid-19 vaccine manufacturer has shown interest yet.


Source: Hindustan Times May 18, 2021 07:29 UTC



Loading...
Loading...
  

Loading...